skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Request a Free Demo of BioMedTracker

 



All the pharmaceutical intelligence you need, in one easy to search web-based database.

 

Learn why pharmaceutical, biotech, and investment companies rely on BioMedTracker for its insight on the likelihood of approval, commercial potential, and future data and regulatory catalysts for drugs within the competitive landscape of every important disease and indication.

 

Biomedtracker-demo

 

With BioMedTracker you get:

 

  • Competitive Landscaping Tools and Analysis
  • Detailed Drug and Clinical Trial Analysis
  • Company Pipeline Valuations
  • Dynamic Revenue Modeling
  • Fully Searchable Catalyst Calendar
  • Access to BioMedTracker Analysts
  • Custom Email Alerts and Portfolio Tracking

 

 

 Get a free demonstration of BioMedTracker's pharmaceutical intelligence database to see how it works.

 

Hands down, the best, most complete database of historical clinical trial data and upcoming clinical and regulatory catalysts I've ever used.

 

-Adam Feuerstein Senior Biotech Columnist for the TheStreet.com


Read also

  • Datamonitor Healthcare: data analysis and insight, Biomedtra...

    Gene therapy manufacturers

    Given the transformative nature of regenerative medicines, which can yield greatly improved patient responses, meet unmet need, and now exist as viable products on the market, cell and gene therapeutics developers over the past several years have been drawing deal attention, not only through collaborative partnerships, but also as acquisition targets.

  • Biomedtracker: see the drug development process through anal...

    Deconstructing the KRAS+ market opportunity

    By Daniel Chancellor

    With arguably the standout data from the 2019 American Society for Clinical Oncology (ASCO) annual meeting, Amgen has become the first company to show that KRAS, beyond its role as an oncogene, is also a viable drug target

    Topics BioPharmaceutical Drug Review

  • Biomedtracker: see the drug development process through anal...

    COVID-19 Infographic

    Access the infographic below which explores the number of treatment drugs for COVID-19 currently in clinical trials or in development, events including progress updates, partnerships, regulatory and trial announcements etc, and the number of articles published on COVID-19 as of March 3, 2020. This data has been tracked and reported via Informa Pharma Intelligence’s clinical, regulatory and commercial data and analytics, and news and insight tools including Biomedtracker, Trialtrove, Pharmaprojects, Scrip, Pink Sheet, Medtech Insight, and Generics Bulletin etc.

    Topics Coronavirus

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: